Molecular Pathology & Genomics
To be a world class division of LMP that provides department, collegiate and national leadership in the pursuit of excellence in molecular pathology and genomic research, education and clinical service
To foster a culture of innovation and academic excellence by promoting synergistic collaborations among members of the Division of Molecular Pathology and Genomics
Grand Rounds sponsored by the Division of Molecular Pathology and Genomics
October 31, 2018
Assistant Professor, Department of Pharmacy Practice and Pharmaceutical Sciences
College of Pharmacy, University of Minnesota - Duluth
Annual MPG Symposium
The first annual MPG Symposium, "New Approaches for Monitoring Disease Detection in Oncology," was held October 11, 2018 at Coffman Memorial Union. The keynote speaker was the University of Michigan's Muneesh Tewari, MD, PhD. The title of his talk was: The integration of cell free DNA with wearable sensors for early cancer diagnosis.
The symposium featured three additional presentations:
"Clinical significance of sinonasal teratocarcinoma (SNTCS)," Kevin Ha, DO, Blood Bank / Transfusion Medicine fellow
"Single cell sequencing of macrophages in the primary and metastatic tumor environments," Danielle Renner, PhD
"GenReport: A free literature review tool for genetic variants," Spencer Kelley and Travis Rogers
Recent MPG Faculty Publications
Yang R, Van Etten JL, Dehm SM. Indel detection from DNA and RNA sequencing data with transIndel. BMC Genomics. 2018 Apr 19;19(1):270. doi: 10.1186/s12864-018-4671-4.
Rashidi A, Nelson AC, Linden MA, Weisdorf DJ, Dolan MM, Ustun C. Genomics of clonal evolution in a case of essential thrombocythemia. Leuk Lymphoma. 2018 Feb;59(2):497-500. doi: 10.1080/10428194.2017.1337113. Epub 2017 Jun 11.
Pérez Ortiz JM, Orr HT. Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies. Adv Exp Med Biol. 2018;1049:135-145. doi: 10.1007/978-3-319-71779-1_6.
Lou E, D'Souza D, Nelson AC. Therapeutic Response of Metastatic Colorectal Cancer Harboring a KRAS Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumab.J Natl Compr Canc Netw. 2017 Apr;15(4):427-432. PMID:28404754